MRM — MEDIROM Healthcare Technologies Income Statement
0.000.00%
Last trade - 00:00- $3.74m
- $13.83m
- ¥7bn
Annual income statement for MEDIROM Healthcare Technologies, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 20-F | 20-F | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 3,908 | 3,342 | 5,410 | 6,954 | 6,828 |
| Cost of Revenue | |||||
| Gross Profit | 951 | 429 | 1,415 | 1,902 | 1,569 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 3,867 | 3,976 | 5,853 | 6,857 | 7,220 |
| Operating Profit | 40.8 | -635 | -443 | 97 | -392 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 32.7 | -627 | -414 | 180 | 20.6 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 16.8 | -539 | -991 | 149 | 115 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 16.8 | -539 | -991 | 149 | 115 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 17.3 | -539 | -991 | 149 | 115 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 7.64 | -135 | -196 | 29.2 | -29.4 |